News | Wearables | October 15, 2021

Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series

The Biotricity Biocare Cardiac app for the Samsung Galaxy Watch4 offers mobile cardiac telemetry with real-time monitoring and transmission of ECG information. It also can interface with FDA-cleared devices, including a digital thermometer, a pulse oximeter and a blood pressure cuff.
The Biotricity Biocare Cardiac app for the Samsung Galaxy Watch4 offers mobile cardiac telemetry with real-time monitoring and transmission of ECG information. It also can interface with FDA-cleared devices, including a digital thermometer, a pulse oximeter and a blood pressure cuff.

October 15, 2021 — Biotricity Inc. announced the release of Biocare Cardiac, a personal, cardiac health application for individuals diagnosed with or at risk for cardiovascular disease. Designed to be used with Samsung's Galaxy Watch4 smartwatch series, the Biocare Cardiac application continuously collects users' daily activities and provides critical information on their heart performance, empowering patients to better understand and manage their heart conditions. 

Many at-risk cardiac patients only visit a doctor every six months to a year and have limited tools and resources to help them manage their cardiac health every day. The new application is designed to help patients between doctor visits by engaging with a wearable device to help them in lifestyle management activities in a way that will help their doctors make diagnoses augmented with daily medical data related to ECG, SpO2, heart rate, weight and details on fitness and exercise.

"Wearable devices have incredible potential in the healthcare industry, giving individuals information to use in conversations with their doctors and gain a better understanding of their health. The Biocare Cardiac application for Samsung's Galaxy Watch4 series is a great example of this. The application can help make it easier for at-risk individuals to monitor their cardiac health with their doctor and make healthy lifestyles decisions to enhance their quality of life," said Dr. Hon Pak, chief medical officer, Samsung Electronics America.

This new application is designed to be used as part of Biotricity's complete cardiac solution. This includes:
   • Biocare Telemed: a virtual clinic platform with secure HIPAA compliant technology that enables patients to receive care from cardiac physicians remotely.
   • Bioflux Diagnostics: a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ECG information.
   • Biokit: a personal medical device kit bundled for home-use comprised of FDA approved devices including a digital thermometer, a pulse oximeter, a blood pressure cuff and now, the Galaxy Watch4 series.
   • Bioheart: a personal, consumer heart monitor for long-term heart rhythm data collection.
   • Galaxy Watch4 Series: Equipped with an advanced suite of health and wellness features, including the ability to detect an AFib irregular heartbeat, measure blood oxygen level, calculate body composition and track physical activity. This is Samsung's first smartwatch to feature the new Wear OS Powered by Samsung, built jointly with Google.

Biocare Cardiac and Biocare Telemed are fully compatible with Google Wear OS, Android, and iOS and can be downloaded via the App Store or the Play Store.

Biocare Cardiac and Telemed offer full lifecycle care for individuals interested in improving their heart health. If an individual or a loved one is concerned about their heart health, they can pre-download Biocare Cardiac via the Google Play Store or the Apple App Store and stay up to date as we launch.

For more information: www.biotricity.com

Find more technology news on cardiac wearable devices

Related Content

News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | Cardiac Diagnostics

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

Home March 08, 2021
Home
News | Cardiac Diagnostics

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
News | Cardiac Diagnostics

February 2, 2021 — A new study has found in the U.S. shows higher economic prosperity was associated with a small ...

Home February 02, 2021
Home
News | Cardiac Diagnostics

January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects ...

Home January 06, 2021
Home
Subscribe Now